Latest filing published 12 Jun 2023 for FILANA THERAPEUTICS, INC., €883. Read the official filing
No signal scores available.
Patrick J. Md Phd Scannon discloses dealings in 2 companies, chiefly Filana Therapeutics, Inc. and XOMA Royalty Corp. Over a trading history stretching from 1 February 2016 to 12 June 2023, the count stands at 2 filings.
On the market, this insider has only sold: 1 sale. The amount is not disclosed for 1 filing. The rest of the record consists of 1 option exercise.
The record was last updated on 12 June 2023 with an option exercise (€883) in Filana Therapeutics, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations